In conclusion, this study utilizes several cohorts to identify the generally overexpressed HNRNPs, HNRNPL, in PC and demonstrates that downregulation of HNRNPL inhibits pancreatic cancer progression. The gene discussed is HNRNPL; the disease is pachyonychia congenita.